- Release Date: 13/05/25 14:06
- Summary: NEU receives FDA minutes and re-confirms Phase 3 endpoints
- Price Sensitive: No
- Download Document 161.63KB
- Forums
- ASX - By Stock
- NEU
- Ann: NEU receives FDA minutes and re-confirms Phase 3 endpoints
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.13%
!
$17.10

Ann: NEU receives FDA minutes and re-confirms Phase 3 endpoints
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.10 |
Change
-0.195(1.13%) |
Mkt cap ! $2.164B |
Open | High | Low | Value | Volume |
$17.08 | $17.67 | $16.97 | $4.067M | 234.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 227 | $17.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.10 | 38 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 227 | 17.090 |
12 | 1638 | 17.080 |
8 | 971 | 17.070 |
6 | 551 | 17.060 |
5 | 992 | 17.050 |
Price($) | Vol. | No. |
---|---|---|
17.100 | 38 | 3 |
17.110 | 310 | 4 |
17.120 | 717 | 10 |
17.130 | 510 | 9 |
17.140 | 2875 | 9 |
Last trade - 13.33pm 01/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
SPONSORED BY The Market Online